Growth Metrics

Invivyd (IVVD) Shares Outstanding (Weighted Average) (2020 - 2025)

Invivyd posted quarterly Shares Outstanding (Weighted Average) of $172.2 million for Q4 2025, up 45.26% year-on-year from $118.6 million in Q4 2024, and up 25.82% on a QoQ basis from $136.9 million in Q3 2025.

Invivyd (IVVD) has 6 years of Shares Outstanding (Weighted Average) data on file, last reported at $172.2 million in Q4 2025.

  • For the quarter ending Q4 2025, Shares Outstanding (Weighted Average) rose 45.26% year-over-year to $172.2 million; the trailing twelve-month figure through Dec 2025 stood at $172.2 million (up 45.26% YoY), and the FY2025 full-year result was $172.2 million, up 45.26% from the prior year.
  • Shares Outstanding (Weighted Average) for Q4 2025 stood at $172.2 million, up from $136.9 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $172.2 million in Q4 2025 and bottomed at $249769.0 in Q2 2021.
  • The 5-year median for Shares Outstanding (Weighted Average) is $109.3 million (2023), against an average of $105.0 million.
  • The widest annual swing landed in 2022, when Shares Outstanding (Weighted Average) surged 43206.77%; it then increased 0.49% in 2025.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $42.6 million in 2021, then surged by 154.02% to $108.3 million in 2022, then gained by 1.16% to $109.5 million in 2023, then advanced by 8.24% to $118.6 million in 2024, then jumped by 45.26% to $172.2 million in 2025.
  • The last three Shares Outstanding (Weighted Average) figures came in at $172.2 million (Q4 2025), $136.9 million (Q3 2025), and $120.0 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 177,333.76 Bn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 185,491.37 Bn
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 100.00 Bn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 55.66 Bn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 118.76 Bn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 254.10 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - 16.04 Bn
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 104.00 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 132.89 Mn
10 Invivyd 208.38 Mn -18.31 Mn - 172.21 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 172.21 Mn
Sep 30, 2025 136.87 Mn
Jun 30, 2025 119.95 Mn
Mar 31, 2025 119.88 Mn
Dec 31, 2024 118.56 Mn
Sep 30, 2024 118.16 Mn
Jun 30, 2024 119.36 Mn
Mar 31, 2024 115.62 Mn
Dec 31, 2023 109.53 Mn
Sep 30, 2023 109.33 Mn
Jun 30, 2023 109.12 Mn
Mar 31, 2023 108.79 Mn
Dec 31, 2022 108.27 Mn
Sep 30, 2022 108.42 Mn
Jun 30, 2022 108.17 Mn
Mar 31, 2022 107.87 Mn
Dec 31, 2021 42.62 Mn
Sep 30, 2021 61.30 Mn
Jun 30, 2021 249,769.00
Dec 31, 2020 3.61 Mn